Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale
https://www.fiercebiotech.com/biotech/pfizer-pivots-early-stage-rare-disease-rd-shifting-external-innovation-and-putting-assets
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.